Service and Maintenance Agreement for six (6) Applied Biosystems 7500 Fast Real Time Polymerase Chain Reaction (PCR) Systems.

The U.S. Food and Drug Administration (FDA) is soliciting quotes for a one-year Service and Maintenance Agreement covering six Applied Biosystems 7500 Fast Real Time Polymerase Chain Reaction (PCR) Systems at its New York Human and Animal Food Laboratory. The contract requires offerors to provide formally trained and certified Original Equipment Manufacturer (OEM) technicians to deliver unlimited corrective, remedial, and preventive maintenance services, inclusive of shipping, labor, travel, and replacement parts. Key requirements include at least one on-site visit annually for calibration and certification, corrective repair response within 2-3 business days, unlimited technical support Monday through Friday from 8:00 AM to 4:00 PM Eastern Time (excluding federal holidays), and detailed field service reports following each service visit. The solicitation is unrestricted and open to full and open competition with no specified evaluation criteria provided in the available documentation. Quotes must be submitted electronically to howard.nesmith@fda.hhs.gov by 1:00 PM Central Time on April 10, 2026, with all offerors required to be registered and active in SAM.gov with a valid UEI at the time of submission.

This is a Firm-Fixed-Price contract with no set-aside designations, meaning it is available to contractors of all business sizes under the NAICS code 811210 (Electronic and Precision Equipment Repair and Maintenance) with a Small Business Size standard of $34.0 million. The solicitation does not identify any current incumbents or provide specific award values or budget ranges. The contract includes a base one-year period with four optional one-year renewal periods, extending potential performance through April 30, 2031. The equipment at the New York facility is used for high-throughput molecular screening of pathogens including Hepatitis A, Norovirus, Cyclospora, E. coli O157:H7, Clostridium botulinum, highly pathogenic influenza A virus, and Bovine Spongiform Encephalopathy detection. Performance will occur at the Jamaica, NY location, and invoices must be submitted electronically through the Invoice Processing Platform (IPP) with payment on a Net 30 day basis after government acceptance of services.